Article Versions Notes

Vuleta Nedic K, Gajovic N, Jovanovic I, Jurisevic M, Jovanovic M, Jakovljević S, Popovic B, Djordjevic J, Ignjatovic V, Vukomanovic V. IL-33 as a Marker of Poor Early Response in Neuroendocrine Tumor Patients Undergoing Peptide Receptor Radionuclide Therapy. International Journal of Molecular Sciences. 2025; 26(17):8526. https://doi.org/10.3390/ijms26178526

Vuleta Nedic, Katarina, Nevena Gajovic, Ivan Jovanovic, Milena Jurisevic, Marina Jovanovic, Slobodan Jakovljević, Bojana Popovic, Jelena Djordjevic, Vesna Ignjatovic, and Vladimir Vukomanovic. 2025. "IL-33 as a Marker of Poor Early Response in Neuroendocrine Tumor Patients Undergoing Peptide Receptor Radionuclide Therapy" International Journal of Molecular Sciences 26, no. 17: 8526. https://doi.org/10.3390/ijms26178526

Vuleta Nedic, K., Gajovic, N., Jovanovic, I., Jurisevic, M., Jovanovic, M., Jakovljević, S., Popovic, B., Djordjevic, J., Ignjatovic, V., & Vukomanovic, V. (2025). IL-33 as a Marker of Poor Early Response in Neuroendocrine Tumor Patients Undergoing Peptide Receptor Radionuclide Therapy. International Journal of Molecular Sciences, 26(17), 8526. https://doi.org/10.3390/ijms26178526